Heart Failure

Heart failure occurs when the heart cannot pump as much blood as the body requires. This ineffective pumping can lead to enlargement of the heart as the myocardium works harder pump the same amount of blood. Heart failure may be caused by defects in the myocardium, such as an a heart attack infarct, or due to structural issues such as severe heart valve regurgitation. Heart failure can be divided into HF with preserved ejection fraction (HFpEF), and HF with reduced ejection fraction (HFrEF). The disease is further divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or hemodynamic support from a left ventricular assist device (LVAD).

FDA sees value in no-implant heart failure device
The new atrial shunt from Alleviant Medical was designed to treat heart failure without leaving a permanent implant behind. The FDA granted the technology its breakthrough device designation and approved additional research.
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders
The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.
‘Incredibly rewarding’: FDA expands total artificial heart study after early success
An additional 15 patients will now receive BiVacor's titanium total artificial heart technology as they wait for a permanent transplant.
Cardiologists perform world’s first leadless LBBAP procedures with Abbott pacemaker
The first-in-human procedures were performed in Prague with the investigational Aveir CSP leadless pacemaker system.
Cardiologists work to standardize the diagnosis and management of acute myocarditis
New expert recommendations from the American College of Cardiology were designed to help cardiologists, primary care physicians, emergency physicians, rheumatologists and other clinicians deliver the best care possible when managing suspected myocarditis.

Mortality risk model combines EHR data, language processing to account for frailty

Applying natural language learning and deep neural networks to mortality risk models could help predict cardiovascular outcomes with more accuracy than modern support vector machines, researchers said at the 67th annual American College of Cardiology conference in Orlando.

March 16, 2018

Heart Failure

FDA sees value in no-implant heart failure device

FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

‘Incredibly rewarding’: FDA expands total artificial heart study after early success

Cardiologists perform world’s first leadless LBBAP procedures with Abbott pacemaker

Cardiologists work to standardize the diagnosis and management of acute myocarditis